General Information of the Compound
Compound ID
CP0029624
Compound Name
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
    Show/Hide
Synonyms
4-(4-Butylpiperidin-1-yl)-1-o-tolylbutan-1-one
4-(4-butylpiperdin-1-yl)-1-(2-methylphenyl)butan-1-one
4-(4-butylpiperidin-1-yl)-1-(2-methylphenyl)butan-1-one
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
AC-42
AC42
AKOS030284249
ANTKBACNWQHQJE-UHFFFAOYSA-N
BDBM50326219
CHEMBL1242950
GTPL289
L019209
NCGC00485453-01
SCHEMBL4504348
ZINC2022527
gamma-(4-Butylpiperidino)-2'-methylbutyrophenone
    Show/Hide
Structure
Formula
C20H31NO
Molecular Weight
301.474
Canonical SMILES
CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1
    Show/Hide
InChI
InChI=1S/C20H31NO/c1-3-4-9-18-12-15-21(16-13-18)14-7-11-20(22)19-10-6-5-8-17(19)2/h5-6,8,10,18H,3-4,7,9,11-16H2,1-2H3
    Show/Hide
InChIKey
ANTKBACNWQHQJE-UHFFFAOYSA-N
Physicochemical Property
logP
4.86012
Rotatable Bonds
8
Heavy Atom Count
22
Polar Areas
20.31
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9948320
SID: 14922979
ChEMBL ID
CHEMBL1242950
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  2
1
EC50 = 150 nM
   TI
   LI
   LO
   TS
2
EC50 = 500 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki >= 1000 nM
Protein ID: PT01198, Muscarinic acetylcholine receptor M2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  1
1
Ki = 980 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki >= 1000 nM
Protein ID: PT01266, Muscarinic acetylcholine receptor M3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000051 BHK-21 Mesocricetus auratus (Golden hamster)  1
1
Ki = 2800 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki >= 1000 nM
Protein ID: PT01156, Muscarinic acetylcholine receptor M4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000051 BHK-21 Mesocricetus auratus (Golden hamster)  1
1
Ki = 1400 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki >= 1000 nM
Protein ID: PT01516, Muscarinic acetylcholine receptor M5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000051 BHK-21 Mesocricetus auratus (Golden hamster)  1
1
Ki = 4500 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki >= 1000 nM
Clinical Information about the Compound
Drug 1 ( 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one )
Drug Name 4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
Target(s)
Opioid receptor mu (MOP)
Inhibitor
Histamine H3 receptor (H3R)
Inhibitor
Muscarinic acetylcholine receptor M3 (CHRM3)
Inhibitor
Dopamine D3 receptor (D3R)
Inhibitor
Acetylcholinesterase (AChE)
Inhibitor
Neurotensin receptor type 1 (NTSR1)
Inhibitor
Melanocortin receptor 4 (MC4R)
Inhibitor
Neuronal acetylcholine receptor alpha-4 (CHRNA4)
Inhibitor
5-HT 3A receptor (HTR3A)
Inhibitor
5-HT 2B receptor (HTR2B)
Inhibitor
Serotonin transporter (SERT)
Inhibitor
Adrenergic receptor alpha-1A (ADRA1A)
Inhibitor
Endothelin A receptor (EDNRA)
Inhibitor
Histamine H1 receptor (H1R)
Inhibitor
Muscarinic acetylcholine receptor M2 (CHRM2)
Inhibitor
Adenosine A1 receptor (ADORA1)
Inhibitor
5-HT 4 receptor (HTR4)
Inhibitor
Histamine H2 receptor (H2R)
Inhibitor
Dopamine transporter (DAT)
Inhibitor
Muscarinic acetylcholine receptor M5 (CHRM5)
Inhibitor
Cannabinoid receptor 1 (CB1)
Inhibitor
Adrenergic receptor alpha-1D (ADRA1D)
Inhibitor
Dopamine D1 receptor (D1R)
Inhibitor
Muscarinic acetylcholine receptor M4 (CHRM4)
Inhibitor
5-HT 2A receptor (HTR2A)
Inhibitor
5-HT 1A receptor (HTR1A)
Inhibitor
Gastrin/cholecystokinin type B receptor (CCKBR)
Inhibitor
Adenosine A3 receptor (ADORA3)
Inhibitor
5-HT 7 receptor (HTR7)
Inhibitor
Melatonin receptor type 1A (MTNR1A)
Inhibitor
Dopamine D2 receptor (D2R)
Inhibitor
Adrenergic receptor alpha-2A (ADRA2A)
Inhibitor
Neuropeptide Y receptor type 1 (NPY1R)
Inhibitor
5-HT 2C receptor (HTR2C)
Inhibitor
Adrenergic receptor beta-1 (ADRB1)
Inhibitor
Neuronal acetylcholine receptor beta-2 (CHRNB2)
Inhibitor
Substance-K receptor (TACR2)
Inhibitor
Adrenergic receptor alpha-1B (ADRA1B)
Inhibitor
Substance-P receptor (TACR1)
Inhibitor
Adenosine A2a receptor (ADORA2A)
Inhibitor
Norepinephrine transporter (NET)
Inhibitor
Glucocorticoid receptor messenger RNA (GCR mRNA)
Inhibitor
Muscarinic acetylcholine receptor M1 (CHRM1)
Inhibitor